The goal of this clinical trial is to see if a new designed optical coherence tomography catheter can be used in bladder cancer in patients undergoing a transurethral resection of a bladder tumour. The main question it aims to answer is:
\- Is the optical coherence tomography catheter feasible in capturing images of bladder tumours and normal bladder wall during a transurethral resection of a bladder tumour?
Participants will undergo measurements with a new optical coherence tomography device during the transurethral resection of their bladder tumour(s).
Age > 18 years.
Have at least 1 suspected bladder tumour seen at cystoscopy.
Have a bladder that is accessible for cystoscopy.
Be in a physical condition to undergo a TURBT.
Pregnant or lactating women.
The only tumour site is at the bladder neck.
The tumour(s) is larger than 2 centimetres in diameter.
>5 tumours present.
Amsterdam UMC
Lead sponsor
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Sponsor institution